References
- Bergqvist C, Vitiligo: EK. A focus on pathogenesis and its therapeutic implications. J Dermatol. 2021;48(3):252–5.
- Ezzedine K, Lim H, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference. Pigment Cell Melanoma Res. 2012;25(3):E1–E13.
- Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev. 2021;41(2):1138–1166.
- Kammeyer A, Willemsen KJ, Ouwerkerk W, et al. Mechanism of action of 4‐substituted phenols to induce vitiligo and antimelanoma immunity. Pigment Cell Melanoma Res. 2019;32(4):540–552.
- Vrijman C, Willemsen K, Tjin E, et al. T‐cell responses against 4‐tert‐butylphenol‐exposed pigmented cells in a patient with occupational vitiligo. Br J Dermatol. 2019;181(2):387.
- Hariharan V, Klarquist J, Reust MJ, et al. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. J Invest Dermatol. 2010;130(1):211–220.
- Shakshouk H, Lehman JS, editors. Chemical-associated vitiligo. Mayo Clinic Proceedings. Elsevier; 2020.
- Ghosh S. Chemical vitiligo: a subset of vitiligo. Indian J Dermatol. 2020;65(6):443.
- Jeon IK, Park CJ, Lee M-H, et al. A multicenter collaborative study by the Korean Society of Vitiligo about patients’ occupations and the provoking factors of vitiligo. Ann Dermatol. 2014;26(3):349–356.
- Amira S. Les risques professionnels par métiers Synthèse.Stat’ Dares. In: Enquête SUMER. 5. 2014. p. 221.
- van Geel N, Lommerts J, Bekkenk M, et al. Development and validation of the vitiligo extent score (VES): an international collaborative initiative. J Invest Dermatol. 2016;136(5):978–984.
- Harris JE. Chemical-induced vitiligo. Dermatol Clin. 2017;35(2):151–161.
- R Core Team. (2014). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
- Ezzedine K, Eleftheriadou V, Whitton M. Eleftheriadou v, Whitton M and van Geel N: vitiligo. Lancet. 2015;386(9988):74–84.
- Lee H, Lee M-H, Lee DY, et al. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J. 2015;56(3):719–725.
- Jin Y, Santorico SA, Spritz RA. Pediatric to adult shift in vitiligo onset suggests altered environmental triggering. J Invest Dermatol. 140(1):241-3. e4; 2020 doi:10.1016/j.jid.2019.06.131
- Bonamonte D, Vestita M, Romita P, et al. Chemical leukoderma. Dermatitis. 2016;27(3):90–99.
- Jappe U, Geier J, Hausen B. Contact vitiligo following a strong patch test reaction to triglycidyl‐p‐aminophenol in an aircraft industry worker: case report and review of the literature. Contact Dermatitis. 2005;53(2):89–92.
- Kahn G. Depigmentation caused by phenolic detergent germicides. Arch Dermatol. 1970;102(2):177–187.
- Taylor J, Maibach H, Fisher A, et al. Contact leukoderma associated with the use of hair colors. Cutis. 1993;52(5):273–280.
- Boissy RE, Manga P. On the etiology of contact/occupational vitiligo. Pigment Cell Res. 2004;17(3):208–214.
- Mathias CT, Maibach HI, Conant MA. Perioral leukoderma simulating vitiligo from use of a toothpaste containing cinnamic aldehyde. Arch Dermatol. 1980;116(10):1172–1173.
- Odedra S, Yoo J. The risk of chemical leucoderma with skin-lightening therapies. In: Clinical and experimental dermatology. 2021.
- Chan OB, Su JC, Yazdabadi A, et al. Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor. Asia‐Pacific Journal of Clinical Oncology. 2021;18(2):e154–e156.
- Das A, Ghosh A, Kumar P. Chemical leukoderma due to hydroquinone: an unusual phenomenon. Indian J Dermatol Venereol Leprol. 2019;85(5):567.